Arrowhead Pharmaceuticals Inc. buy Cantor Fitzgerald
Start price
08.08.23
/
50%
€25.07
Target price
08.08.24
€42.87
Performance (%)
-10.25%
End price
09.08.24
€22.50
Summary
This prediction ended on 09.08.24 with a price of €22.50. The price of Arrowhead Pharmaceuticals Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.25%. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Arrowhead Pharmaceuticals Inc. | 7.386% | 7.386% | 307.410% |
| iShares Core DAX® | -1.742% | -10.677% | -0.889% |
| iShares Nasdaq 100 | -2.583% | -3.319% | 11.124% |
| iShares Nikkei 225® | -1.165% | -9.362% | 23.687% |
| iShares S&P 500 | -1.422% | -3.762% | 7.187% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its price target lowered by analysts at Cantor Fitzgerald from $79.00 to $47.00. They now have an "overweight" rating on the stock.
Ratings data for ARWR provided by MarketBeat
In the thread Trading Arrowhead Pharmaceuticals Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Cantor_Fitzgerald for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€19.41
09.09.24
09.09.24
-
09.09.25
09.09.25
20.97%
10.09.25
10.09.25
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€22.21
20.06.24
20.06.24
-
20.06.25
20.06.25
-39.53%
21.06.25
21.06.25